Cao C, Xi L, Chaturvedi V. Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: insights into the clinical trends of a major fungal disease 60 years after the discovery of the pathogen. Mycopathologia. 2019;184(6):709–20.

Article  PubMed  Google Scholar 

Capponi M, Segretain G, Sureau P. Penicillosis from Rhizomys sinensis. Bull Soc Pathol Exot Filiales. 1956;49(3):418–21.

CAS  PubMed  Google Scholar 

Qiu Y, Feng X, Zeng W, Zhang H, Zhang J. Immunodeficiency disease spectrum in HIV-negative individuals with talaromycosis. J Clin Immunol. 2021;41(1):221–3.

Article  PubMed  Google Scholar 

Liu L, Sun B, Ying W, Liu D, Wang Y, Sun J, et al. Rapid diagnosis of Talaromyces marneffei infection by metagenomic next-generation sequencing technology in a Chinese cohort of inborn errors of immunity. Front Cell Infect Microbiol. 2022;12:987692.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiu Y, Zeng W, Zhang H, Zhong X, Tang S, Zhang J. Comparison of pleural effusion features and biomarkers between talaromycosis and tuberculosis in non-human immunodeficiency virus-infected patients. BMC Infect Dis. 2019;19(1):745.

Article  PubMed  PubMed Central  Google Scholar 

Fan JH, Luo HY, Yang LG, Wang MY, Xiao ZH. Penicilliosis marneffei in HIV negative children: three case reports. Ann Palliat Med. 2021;10(7):8437–47.

Article  PubMed  Google Scholar 

Yang D, Shen LX, Chen RF, Fu Y, Xu HY, Zhang LN, et al. The Effect of Talaromyces marneffei Infection on CD86 Expression in THP-1 Cells. Infect Drug Resist. 2021;14:651–60.

Article  PubMed  PubMed Central  Google Scholar 

You CY, Hu F, Lu SW, Pi DD, Xu F, Liu CJ, et al. Talaromyces marneffei infection in an HIV-negative child with a CARD9 mutation in china: a case report and review of the literature. Mycopathologia. 2021;186(4):553–61.

Article  PubMed  PubMed Central  Google Scholar 

Ba H, Peng H, Cheng L, Lin Y, Li X, He X, et al. Case report: talaromyces marneffei Infection in a Chinese child with a complex heterozygous CARD9 mutation. Front Immunol. 2021;12:685546.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo J, Li BK, Li TM, Wei FL, Fu YJ, Zheng YQ, et al. Characteristics and prognosis of talaromyces marneffei Infection in Non-HIV-Infected Children in Southern China. Mycopathologia. 2019;184(6):735–45.

Article  CAS  PubMed  Google Scholar 

Du X, Tang W, Chen X, Zeng T, Wang Y, Chen Z, et al. Clinical, genetic and immunological characteristics of 40 Chinese patients with CD40 ligand deficiency. Scand J Immunol. 2019;90(4):e12798.

Article  PubMed  Google Scholar 

Chen X, Xu Q, Li X, Wang L, Yang L, Chen Z, et al. Molecular and phenotypic characterization of nine patients with STAT1 GOF mutations in China. J Clin Immunol. 2020;40(1):82–95.

Article  PubMed  Google Scholar 

Zhang W, Ye J, Qiu C, Wang L, Jin W, Jiang C, et al. Rapid and precise diagnosis of T. marneffei pulmonary infection in a HIV-negative patient with autosomal-dominant STAT3 mutation: a case report. Ther Adv Respir Dis. 2020;14:1753466620929225.

Article  PubMed  PubMed Central  Google Scholar 

Xue X, Zou J, Fang W, Liu X, Chen M, Arastehfar A, et al. Characteristics and prognosis of talaromyces marneffei infection in HIV-positive children in Southern China. Mycopathologia. 2022;187(2–3):169–80.

Article  CAS  PubMed  Google Scholar 

Li X, Hu W, Wan Q, Lei Q, Sun C, Hou Z, et al. Non-HIV talaromycosis: radiological and clinical analysis. Medicine (Baltimore). 2020;99(10):e19185.

Article  PubMed  Google Scholar 

Ding X, Huang H, Zhong L, Chen M, Peng F, Zhang B, et al. Disseminated talaromyces marneffei infection in a non-HIV infant with a homozygous private variant of RELB. Front Cell Infect Microbiol. 2021;11:605589.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhan Y, Lu C, Li S, Zhao J, Li Z, Gu Y, et al. Successful management of mixed mycosis in HIV-negative patients with different immune status: a case series report. Front Cell Infect Microbiol. 2022;12:851891.

Article  PubMed  PubMed Central  Google Scholar 

Pan M, Huang J, Qiu Y, Zeng W, Li Z, Tang S, et al. Assessment of talaromyces marneffei infection of the intestine in three patients and a systematic review of case reports. Open Forum Infect Dis. 2020;7(6):ofaa128.

Article  PubMed  PubMed Central  Google Scholar 

Qiu Y, Zhang J, Liu G, Zhong X, Deng J, He Z, et al. Retrospective analysis of 14 cases of disseminated Penicillium marneffei infection with osteolytic lesions. BMC Infect Dis. 2015;15:47.

Article  PubMed  PubMed Central  Google Scholar 

Li D, Liang H, Zhu Y, Chang Q, Pan P, Zhang Y. Clinical Characteristics, laboratory findings, and prognosis in patients with talaromyces marneffei infection across various immune statuses. Front Med (Lausanne). 2022;9:841674.

Article  PubMed  Google Scholar 

Shi M, Lin J, Wei W, Qin Y, Meng S, Chen X, et al. Machine learning-based in-hospital mortality prediction of HIV/AIDS patients with Talaromyces marneffei infection in Guangxi, China. PLoS Negl Trop Dis. 2022;16(5):e0010388.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu Y, Zhang J, Li X, Yang Y, Zhang Y, Ma J, et al. Penicillium marneffei infection: an emerging disease in mainland China. Mycopathologia. 2013;175(1–2):57–67.

Article  PubMed  Google Scholar 

Thu NTM, Chan JFW, Ly VT, Ngo HT, Hien HTA, Lan NPH, et al. Superiority of a novel Mp1p antigen detection enzyme immunoassay compared to standard BACTEC blood culture in the diagnosis of talaromycosis. Clin Infect Dis. 2021;73(2):e330–6.

Article  CAS  PubMed  Google Scholar 

Pruksaphon K, Intaramat A, Simsiriwong P, Mongkolsuk S, Ratanabanangkoon K, Nosanchuk JD, et al. An inexpensive point-of-care immunochromatographic test for Talaromyces marneffei infection based on the yeast phase specific monoclonal antibody 4D1 and Galanthus nivalis agglutinin. PLoS Negl Trop Dis. 2021;15(5):e0009058.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng Q, Jin Y, Yin G, Yang D, Li W, Shi T, et al. Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases. BMC Infect Dis. 2021;21(1):287.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu D, Zhong LL, Li Y, Chen M. Recurrent fever, hepatosplenomegaly and eosinophilia in a boy. Zhongguo Dang Dai Er Ke Za Zhi. 2016;18(11):1145–9.

PubMed  Google Scholar 

Le T, Kinh NV, Cuc NTK, Tung NLN, Lam NT, Thuy PTT, et al. A trial of itraconazole or amphotericin B for HIV-associated talaromycosis. N Engl J Med. 2017;376(24):2329–40.

Article  CAS  PubMed  Google Scholar 

Nelson M, Dockrell D, Edwards S, Subcommittee BG, Angus B, Barton S, et al. British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med. 2011;12(Suppl 2):1–140.

Article  PubMed  Google Scholar 

Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutierrez F, et al. Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015. Enferm Infecc Microbiol Clin. 2016;34(8):516.e1-e18.

Article  PubMed  Google Scholar 

Pan M, Qiu Y, Zeng W, Tang S, Wei X, Zhang J. Disseminated Talaromyces marneffei infection presenting as multiple intestinal perforations and diffuse hepatic granulomatous inflammation in an infant with STAT3 mutation: a case report. BMC Infect Dis. 2020;20(1):394.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klus J, Ly VT, Chan C, Le T. Prognosis and treatment effec